Oh Ching Mien, Heng Paul Wan Sia, Chan Lai Wah
GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.
AAPS PharmSciTech. 2015 Dec;16(6):1357-67. doi: 10.1208/s12249-015-0320-2. Epub 2015 May 2.
The purpose of this study was to investigate the effect of a hydrophilic polymer, hydroxypropyl methylcellulose (HPMC), on the crystallinity and drug release of metronidazole (MNZ) in spray-congealed polyethylene glycol (PEG) microparticles and to further modify the drug release using other additives in the formulation. HPMC has been used in many pharmaceutical formulations and processes but to date, it has not been employed as an additive in spray congealing. Crystallinity of a drug is especially important to the development of pharmaceutical products as active pharmaceutical ingredients (APIs) are mostly crystalline in nature. A combination of X-ray diffractometry, differential scanning calorimetry, Raman spectroscopy and Fourier transform-infrared spectroscopy (FT-IR) spectroscopy was employed to investigate the degree of crystallinity and possible solid-state structure of MNZ in the microparticles. The microparticles with HPMC were generally spherical. Spray congealing decreased MNZ crystallinity, and the presence of HPMC reduced the drug crystallinity further. The reduction in MNZ crystallinity was dependent on the concentration of HPMC. Smaller HPMC particles also resulted in a greater percentage reduction in MNZ crystallinity. Appreciable modification to MNZ release could be obtained with HPMC. However, this was largely attributed to the role of HPMC in forming a diffusion barrier. Further modification of drug release from spray-congealed PEG-HPMC microparticles was achieved with the addition of 5% w/w dicalcium phosphate but not with magnesium stearate, methyl cellulose, polyvinylpyrrolidone, silicon dioxide and sodium oleate/citric acid. Dicalcium phosphate facilitated formation of the diffusion barrier.
本研究的目的是考察亲水性聚合物羟丙基甲基纤维素(HPMC)对喷雾冷凝法制备的聚乙二醇(PEG)甲硝唑(MNZ)微粒结晶度及药物释放的影响,并进一步通过在制剂中添加其他辅料来调控药物释放。HPMC已被广泛应用于多种药物制剂及工艺中,但迄今为止,尚未用作喷雾冷凝法的辅料。药物的结晶度对于药品研发尤为重要,因为活性药物成分(API)大多为晶态物质。采用X射线衍射法、差示扫描量热法、拉曼光谱法和傅里叶变换红外光谱(FT-IR)法相结合,考察MNZ在微粒中的结晶度及可能的固态结构。含HPMC的微粒通常呈球形。喷雾冷凝降低了MNZ的结晶度,且HPMC的存在进一步降低了药物的结晶度。MNZ结晶度的降低取决于HPMC的浓度。较小的HPMC颗粒也导致MNZ结晶度的降低百分比更大。HPMC可显著改变MNZ的释放。然而,这在很大程度上归因于HPMC形成扩散屏障的作用。通过添加5% w/w的磷酸氢钙而非硬脂酸镁、甲基纤维素、聚乙烯吡咯烷酮、二氧化硅和油酸钠/柠檬酸,可进一步调控喷雾冷凝法制备的PEG-HPMC微粒的药物释放。磷酸氢钙有助于形成扩散屏障。